BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND AKAP9, AKAP350, 10142, ENSG00000127914, KIAA0803, Q99996, AKAP450, YOTIAO, PRKA9, HYPERION, MU-RMS-40_16A, CG-NAP
11 results:

  • 1. The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid.
    Jordan TJM; Chen J; Li N; Burette S; Wan L; Chen L; Culton DA; Geng S; Googe P; Thomas NE; Diaz LA; Liu Z
    J Immunol; 2023 Oct; 211(8):1216-1223. PubMed ID: 37672029
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [1,2,4]triazolo[4,3-
    Patinote C; Raevens S; Baumann A; Pellegrin E; Bonnet PA; Deleuze-Masquéfa C
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513350
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Design, Synthesis, and Antiproliferative Activity of Novel Neocryptolepine-Rhodanine Hybrids.
    El-Bahnsawye M; Hussein MKA; Elmongy EI; Awad HM; Tolan AAE; Moemen YS; El-Shaarawy A; El-Sayed IE
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364427
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis.
    Wu X; Zhao J
    Medicine (Baltimore); 2021 Feb; 100(8):e24866. PubMed ID: 33663112
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Giant Congenital Melanocytic Nevus Treated With Trametinib.
    Mir A; Agim NG; Kane AA; Josephs SC; Park JY; Ludwig K
    Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30792255
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations.
    Davidson G; Coassolo S; Kieny A; Ennen M; Pencreach E; Malouf GG; Lipsker D; Davidson I
    J Invest Dermatol; 2019 Aug; 139(8):1769-1778.e2. PubMed ID: 30776432
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Unclassified sclerosing malignant melanomas with akap9-BRAF gene fusion: a report of two cases and review of BRAF fusions in melanocytic tumors.
    Perron E; Pissaloux D; Neub A; Hohl D; Tartar MD; Mortier L; Alberti L; de la Fouchardiere A
    Virchows Arch; 2018 Mar; 472(3):469-476. PubMed ID: 29464327
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity.
    Segaoula Z; Leclercq J; Verones V; Flouquet N; Lecoeur M; Ach L; Renault N; Barczyk A; Melnyk P; Berthelot P; Thuru X; Lebegue N
    J Med Chem; 2016 Sep; 59(18):8422-40. PubMed ID: 27538123
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Activity guided isolation and modification of juglone from Juglans regia as potent cytotoxic agent against lung cancer cell lines.
    Zhang XB; Zou CL; Duan YX; Wu F; Li G
    BMC Complement Altern Med; 2015 Nov; 15():396. PubMed ID: 26530090
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrative genome comparison of primary and metastatic melanomas.
    Kabbarah O; Nogueira C; Feng B; Nazarian RM; Bosenberg M; Wu M; Scott KL; Kwong LN; Xiao Y; Cordon-Cardo C; Granter SR; Ramaswamy S; Golub T; Duncan LM; Wagner SN; Brennan C; Chin L
    PLoS One; 2010 May; 5(5):e10770. PubMed ID: 20520718
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Monoclonal antibodies specific for subsets of epidermal keratins: biochemical and immunocytochemical characterization--applications in pathology and cell culture.
    Knight J; Gusterson B; Jones RR; Landells W; Wilson P
    J Pathol; 1985 Apr; 145(4):341-54. PubMed ID: 2582105
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.